Vaxcyte COO reports 18,000-share sale
Vaxcyte Chief Operating Officer Jim Wassil reported a sale of 18,000 shares at $86.74 on Oct. 5 under a 10b5-1 plan. The filing also shows an 18,000-share exercise at $5.35.
Vaxcyte Chief Operating Officer Jim Wassil reported a sale of 18,000 shares at $86.74 on Oct. 5 under a 10b5-1 plan. The filing also shows an 18,000-share exercise at $5.35.